false
0001549084
0001549084
2026-06-29
2026-06-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): June 29, 2026
CHRONOSCALE
CORPORATION
(Exact
name of registrant as specified in its charter)
| Nevada |
|
001-37854 |
|
99-0367049 |
| (State
or other jurisdiction |
|
(Commission |
|
(IRS
Employer |
| of
Incorporation) |
|
File
Number) |
|
Identification
Number) |
3811
Turtle Creek Blvd. Suite 2100
Dallas,
Texas |
|
75219 |
| (Address
of registrant’s principal executive office) |
|
(Zip
code) |
214-427-1704
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, par value $0.001 per share |
|
CHRN |
|
Nasdaq
Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.
On
June 29, 2026, the board of directors (the “Board”) of ChronoScale Corporation, a Nevada corporation (the “Company”),
increased the size of the Board from seven to eight members and appointed Mr. Andrew Cordell Schaap to serve as a member of the
Board to fill the resulting vacancy, effective as of June 29, 2026. In addition, Mr. Schaap was appointed to serve as a member of each
of (i) the Audit Committee of the Board, replacing Douglas Miller who will continue to serve on the Board, and (ii) the Related
Party Transactions Committee of the Board, each effective as of June 29, 2026.
There
are no related party transactions reportable under Item 5.02 of Form 8-K and Item 404(a) of Regulation S-K with respect to Mr.
Schaap and the Company. For informational purposes, the Company discloses that its subsidiary is
a party to a data center lease with a company in which Mr. Schaap is Chief Executive Officer and a member of the board of directors. The lease was previously entered into in the ordinary course of business.
Upon
his appointment, Mr. Schaap was granted a Restricted Stock Award (the “Schaap RSA”) under the Company’s 2026
Omnibus Equity Incentive Plan (as amended from time to time, the “2026 Plan”). The Schaap RSA consists of two hundred
thousand restricted shares of common stock of the Company, par value $0.001 per share (the “Common
Stock”). The Schaap RSA will vest in two equal annual installments on each of the first two anniversaries of the date
of grant; provided, that Mr. Schaap continues to provide service to the Company on the applicable vesting date. In addition,
the Schaap RSA will accelerate and vest upon certain conditions as set forth therein.
The
foregoing description of the Schaap RSA is not complete and is qualified in its entirety to the full text of the Restricted Stock Award
Agreement by and between the Company and Mr. Schaap, a copy of which is incorporated by reference as Exhibit 10.1 to this Current Report
on Form 8-K and is incorporated by reference herein.
Item
8.01. Other Events.
The
Board has established the following committees of the Board: the Audit Committee, the Compensation Committee, the Nominating and Governance
Committee, and the Related Party Transaction Committee, each comprised as follows as of June 30, 2026:
| Name |
|
Audit
Committee |
|
Compensation
Committee |
|
Nominating
and Governance Committee |
|
Related
Party Transaction Committee |
| Douglas
Miller |
|
|
|
Member |
|
Member |
|
|
| Richard
Nottenburg |
|
|
|
Chair |
|
|
|
|
| Ella
Benson |
|
Member |
|
|
|
Chair |
|
|
| William
M. Clancy |
|
Chair |
|
|
|
|
|
Chair |
| Andrew
Schaap |
|
Member |
|
|
|
|
|
Member |
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
| Exhibit |
|
Description |
| 10.1 |
|
Restricted Stock Award Agreement, dated June 29, 2026, by and between ChronoScale Corporation and Andrew Schaap. |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline
XBRL document). |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
June 30, 2026
| |
CHRONOSCALE
CORPORATION |
| |
|
|
| |
By: |
/s/
Jerome Wong |
| |
Name: |
Jerome
Wong |
| |
Title: |
Chief
Financial Officer |